ADCT — ADC Therapeutics SA Cashflow Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual cashflow statement for ADC Therapeutics SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	20-F	20-F	10-K	10-K
Standards:	IFRS	IFRS	IFRS	USG	USG
Status:	Final	Final	Final	Final	Final
Net Income/Starting Line	-116	-246	-230	-157	-240
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items	0.423	63.8	46.5	65.9	37.2
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital	-7.17	11.6	-26.4	-46.6	45.9
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Change in Payable / Accrued Expenses
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities	-122	-169	-233	-138	-119
Capital Expenditures	-2.15	-2.81	-6.38	-0.687	-3.22
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items	-0.1	-0.019	-0.297	—	—
Other Investing Cash Flow
Cash from Investing Activities	-2.25	-2.83	-6.67	-0.687	-3.22
Financing Cash Flow Items	—	—	—	-1.31	—
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities	101	495	267	-0.897	73.9
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash	-23.3	324	27.3	-140	-47.8